Free Shipping on purchases over €100

Trepatdiet Gynkgomax , 30 tab

Trepatdiet Gynkgomax , 30 tabs

Trepatdiet Gynkgomax 30 Tab is formulated with ginkgo biloba, which complements nutrition thanks to its high antioxidant content. It is indicated for people suffering from dizziness, headaches or dizziness, as its properties act as vasodilators of the nervous system.

 

SKU: TR8008843004003
-17%
Promo FD
24.30
€29.35
€0.81
/1ud

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Trepatdiet Gynkgomax is a food supplement indicated for maintaining good neuronal health. It contains antioxidant properties that help to strengthen the body's natural defences against degenerative damage caused by free radicals. It helps prevent and counteract colds, asthma and bronchitis. It also has an expectorant action which helps to relieve congestion.

Thanks to the properties of ginkgo biloba, it acts as a mental tonic that promotes the proper functioning of the nervous system. It also serves to strengthen cognitive function and memory. It is a product that facilitates the treatment of people with senile dementia and at risk of Alzheimer's disease.

The properties of ginkgo biloba help to counteract circulatory disorders, as it has properties that help to improve blood flow. It is also useful for relieving leg and joint pain, as it has properties that help to optimise muscle function and stimulate good venous return.

Among its benefits, it is a supplement that counteracts stress and anxiety, as well as helping to improve mood. It contributes to providing energy levels for the development of daily activities. It helps to mitigate the tiredness that older adults may experience as a result of their age.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.